Chewy, Inc., is dedicated to the pure business of e-commerce in the United States. The company is headquartered in Dania Beach, Florida.
| Revenue (TTM) | $12.84B |
| Gross Profit (TTM) | $3.84B |
| EBITDA | $399.30M |
| Operating Margin | 3.83% |
| Return on Equity | 63.80% |
| Return on Assets | 6.01% |
| Revenue/Share (TTM) | $31.01 |
| Book Value | $1.03 |
| Price-to-Book | 20.13 |
| Price-to-Sales (TTM) | 0.69 |
| EV/Revenue | 0.662 |
| EV/EBITDA | 18.59 |
| Quarterly Earnings Growth (YoY) | 52.70% |
| Quarterly Revenue Growth (YoY) | 7.70% |
| Shares Outstanding | $232.95M |
| Float | $54.40M |
| % Insiders | 2.63% |
| % Institutions | 99.91% |
Volatility is currently expanding
Chewy (CHWY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Recently, Zacks.com users have been paying close attention to Chewy (CHWY). This makes it worthwhile to examine what the stock has in store.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CHWY is expanding its healthcare platform through Vet Care and Modern Animal to drive customer growth and long-term profitability.
Chewy remains a Strong Buy, with valuation implying a high margin of safety even under conservative assumptions and challenging macro conditions. Q1 delivered 7.7% YoY net sales growth, $71M FCF, record profitability, and nearly 200,000 net customer additions despite consumer headwinds. CHWY's guidance reflects macro pressure: net sales are expected at $13.40–$13.55B and Adj. EBITDA margin at 6.6–6.8%, but long-term potential remains intact.
Chewy is upgraded from Hold to Buy after a 40% stock decline and earnings multiple compression. CHWY's fundamentals have improved, with consistent top and bottom-line growth despite occasional estimate misses. The pet products market remains high-growth, supporting sustained demand and CHWY's upward business trajectory.
Chewy remains a "Buy" despite a ~40% YTD decline and a guidance cut, as I view challenges as cyclical, not structural. CHWY lowered FY26 sales outlook to $13.40–$13.55 billion, citing macro headwinds and consumer trade-down to lower-priced pet products. I see ongoing improvements in margins, customer net additions, and engagement, supporting long-term growth and share gains.
Chewy (CHWY) reported earnings 30 days ago. What's next for the stock?
Retail meme energy has rotated back into three familiar names, and the setups could not be more different.
CHWY strengthens recurring revenues through customer growth, Vet Care expansion and an integrated pet ecosystem.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CHWY and any ticker you trade — then tracks every position and per-strategy win rate.
